
Please try another search
Shanghai MicroPort Endovascular MedTech Co., Ltd. engages in the research and development, manufacturing, and sale of aortic and peripheral vascular medical devices in China and internationally. The company’s products include branched aortic stent graft system, thoracic stent graft system, abdominal aortic stent graft and delivery system, bifurcated stent graft system, and other stent graft system in surgical operation, as well as accessories, such as balloon inflation catheter. Shanghai MicroPort Endovascular MedTech Co., Ltd. was incorporated in 2012 and is based in Shanghai, the People’s Republic of China.
Name | Age | Since | Title |
---|---|---|---|
Chao Guo | 37 | 2023 | Supervisor |
Xiaojie Ye | 38 | 2022 | Independent Director |
Jonathan H. Chen | 49 | 2023 | Chairman |
Qing Zhu | 43 | 2018 | GM & Director |
Linlin Cai | 44 | 2018 | Employee Representative Supervisor |
Min Liang | 38 | 2023 | Chairman of the Supervisory Board |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review